Epigenetic fragility of the endocannabinoid system under stress: risk for mood disorders and pharmacogenomic implications

Epigenomics. 2020 Apr;12(8):657-660. doi: 10.2217/epi-2020-0037. Epub 2020 May 12.

Authors

Sari Goldstein Ferber^{1

2}, Tania L Roth³, Aron Weller^{1

2}

Affiliations

¹ Psychology Department, Bar-Ilan University, Ramat Gan, Israel.
² Gonda Brain Research Center, Bar-Ilan University, Ramat Gan, Israel.
³ Department of Psychological & Brain Sciences, University of Delaware, DE 19716, USA.

PMID: 32396405
DOI: 10.2217/epi-2020-0037

No abstract available

Keywords: 2-AG; CB1; FAAH; anxiety; depression; endocannabinoid System; pharmacogenomics; predisposition.

Publication types

Editorial

MeSH terms

Disease Susceptibility
Endocannabinoids / metabolism*
Epigenesis, Genetic*
Humans
Mood Disorders / drug therapy
Mood Disorders / etiology*
Mood Disorders / metabolism*
Pharmacogenetics
Stress, Physiological*

Substances

Endocannabinoids